{"id":"topical-application-tranexamic-acid","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"5-10%","effect":"Headache"},{"rate":"5-10%","effect":"Dizziness"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This mechanism is particularly useful in conditions where excessive bleeding is a concern, such as in surgical procedures or in patients with bleeding disorders. By inhibiting plasminogen activation, tranexamic acid helps to stabilize blood clots and prevent their breakdown.","oneSentence":"Tranexamic acid works by inhibiting the activation of plasminogen to plasmin, thereby reducing fibrinolysis and improving hemostasis.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:54:20.037Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Surgical bleeding prevention"},{"name":"Menstrual bleeding disorders"}]},"trialDetails":[{"nctId":"NCT07495748","phase":"NA","title":"Comparative Evaluation of Topical Metformin and Topical Tranexamic Acid in Melasma","status":"NOT_YET_RECRUITING","sponsor":"Foundation University Islamabad","startDate":"2026-07-01","conditions":"Melasma","enrollment":70},{"nctId":"NCT07455591","phase":"PHASE4","title":"A Trial of Intraoperative Fibrin Sealant on Postoperative Recovery After Total Knee Replacement","status":"COMPLETED","sponsor":"Singapore General Hospital","startDate":"2024-01-01","conditions":"Osteo Arthritis of the Knee","enrollment":78},{"nctId":"NCT07448415","phase":"PHASE2, PHASE3","title":"Evaluation of the Efficacy of Oral Tranexamic Acid and Glutathione-assisted Microneedling in Treatment of Melasma","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2026-02","conditions":"Melasma","enrollment":42},{"nctId":"NCT07434453","phase":"NA","title":"\"Topical Tranexamic Acid With Flap Fixation: A Novel Approach to Minimize Post-operative Drainage and Surgical Site Infection in Patients Undergoing Modified Radical Mastectomy\"","status":"COMPLETED","sponsor":"Noor ul Ain","startDate":"2023-08-04","conditions":"Breast Cancer Females","enrollment":62},{"nctId":"NCT07362992","phase":"EARLY_PHASE1","title":"Topical Tranexamic Acid to Reduce Blood Loss During Cesarean Delivery","status":"NOT_YET_RECRUITING","sponsor":"Wolfson Medical Center","startDate":"2026-01-01","conditions":"Cesarean Delivery, Postpartum Hemorrhage (PPH), Intraoperative Blood Loss","enrollment":112},{"nctId":"NCT07131592","phase":"PHASE4","title":"Effect of Intravenous and Topical Tranexamic Acid on Drain Output in Breast Reduction Surgery","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2025-11-18","conditions":"Drain Output After Breast Reduction Surgery, Breast Reductions","enrollment":160},{"nctId":"NCT06422273","phase":"PHASE3","title":"Protest Trial: TXA vs Saline","status":"ENROLLING_BY_INVITATION","sponsor":"Corewell Health West","startDate":"2024-04-16","conditions":"Lung Transplant, Complications Surgical","enrollment":94},{"nctId":"NCT07202156","phase":"NA","title":"Ultrasound-Enhanced Delivery of Compound TXA Solution in Melasma","status":"RECRUITING","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2024-10-20","conditions":"Melasma (Facial Melasma)","enrollment":35},{"nctId":"NCT06379724","phase":"PHASE4","title":"Burn Study- Tranexamic Acid Versus Thrombin in Split Thickness Skin Graft","status":"RECRUITING","sponsor":"University of Kansas Medical Center","startDate":"2024-07-11","conditions":"Burns, Skin Graft Complications","enrollment":62},{"nctId":"NCT05807074","phase":"PHASE4","title":"Impact of Topical Tranexamic Acid in Breast Reconstruction","status":"TERMINATED","sponsor":"University of California, San Francisco","startDate":"2023-04-20","conditions":"Breast Cancer","enrollment":23},{"nctId":"NCT06345833","phase":"EARLY_PHASE1","title":"Topical and Local TXA in Facelifts - A Randomized Controlled Double Blinded Study","status":"RECRUITING","sponsor":"University of Minnesota","startDate":"2024-07-01","conditions":"Hemophilia, Hemorrhage, Facelift Surgery","enrollment":50},{"nctId":"NCT06145191","phase":"NA","title":"Prophylactic Tranexamic Acid Versus Adrenaline During Flexible Bronchoscopy","status":"COMPLETED","sponsor":"Clinical Hospital Centre Zagreb","startDate":"2023-12-18","conditions":"Bleeding, Hemoptysis","enrollment":1013},{"nctId":"NCT06644079","phase":"PHASE2","title":"Window of Opportunity Study of Topical Tranexamic Acid for Cutaneous Squamous Cell Carcinoma","status":"WITHDRAWN","sponsor":"University of Florida","startDate":"2025-05","conditions":"Cutaneous Squamous Cell Carcinoma","enrollment":""},{"nctId":"NCT02314988","phase":"PHASE2, PHASE3","title":"Tranexamic Acid to Reduce Blood Loss in Spine Surgery","status":"RECRUITING","sponsor":"Columbia University","startDate":"2020-06-15","conditions":"Spinal Injuries, Spinal Deformity","enrollment":252},{"nctId":"NCT05357079","phase":"EARLY_PHASE1","title":"Impact of Topical Tranexamic Acid on Pre- and Post-operative Hemoglobin/Hematocrit","status":"COMPLETED","sponsor":"University of Cincinnati","startDate":"2017-08-25","conditions":"Fracture of Posterior Wall of Acetabulum","enrollment":94},{"nctId":"NCT06205615","phase":"PHASE2","title":"Treatment of Post-Punch Biopsy Bleeding in Apixaban-Treated Patients Using Self-Administered BXP154B","status":"COMPLETED","sponsor":"Bio 54, LLC","startDate":"2024-01-24","conditions":"Wound Bleeding","enrollment":24},{"nctId":"NCT06876181","phase":"","title":"In Vivo Study of Local Tranexamic Acid Concentrations Following Intra-Articular Administration in Total Knee Arthroplasty","status":"COMPLETED","sponsor":"Valdoltra Orthopedic Hospital","startDate":"2022-08-23","conditions":"Local Concentration of Tranexamic Acid Following Intra-articular Administration in TKA","enrollment":48},{"nctId":"NCT05554211","phase":"PHASE2","title":"Tranexamic Acid Usage in Bilateral Mastectomy to Reduce Post-surgical Drainage","status":"WITHDRAWN","sponsor":"Northwestern University","startDate":"2022-07-12","conditions":"Breast Cancer, BRCA Mutation","enrollment":""},{"nctId":"NCT06270407","phase":"PHASE4","title":"The Effect of Local Application of Tranexamic Acid Versus Placebo on Postoperative Complications in Plastic Surgery","status":"RECRUITING","sponsor":"St. Olavs Hospital","startDate":"2024-10-01","conditions":"Surgical Complication","enrollment":3000},{"nctId":"NCT04541303","phase":"EARLY_PHASE1","title":"Topical Tranexamic Acid Use on Granulating Wounds Following Mohs Micrographic Surgery","status":"COMPLETED","sponsor":"University of Missouri-Columbia","startDate":"2020-10-08","conditions":"Postoperative Wound Haemorrhage","enrollment":124},{"nctId":"NCT05326997","phase":"NA","title":"Treatment of Melasma With Yellow Light Compared to Tranexamic Acid","status":"TERMINATED","sponsor":"University of Nove de Julho","startDate":"2023-05-01","conditions":"Melasma","enrollment":21},{"nctId":"NCT06522984","phase":"NA","title":"Fractional Erbium YAG Laser vs Intradermal and Systemic Tranexamic Acid","status":"RECRUITING","sponsor":"Egymedicalpedia","startDate":"2024-06-01","conditions":"Refractory Melasma","enrollment":45},{"nctId":"NCT06515535","phase":"NA","title":"Efficacy of Topical Tranexamic Acid in Reducing Blood Loss During CS in Patients With Placenta Previa","status":"NOT_YET_RECRUITING","sponsor":"Cairo University","startDate":"2024-07-24","conditions":"Placenta Previa","enrollment":56},{"nctId":"NCT04814433","phase":"PHASE4","title":"Evaluating Postoperative Non-Opioid Pain Management Utilizing Local Anesthetics Coupled With Modulated Coagulation","status":"TERMINATED","sponsor":"NYU Langone Health","startDate":"2021-03-24","conditions":"Opioid Pain Medication","enrollment":46},{"nctId":"NCT06418568","phase":"NA","title":"Efficacy and Safety Trial of Using Ultra-Pulsed Shockwaves to Deliver Tranexamic Acid for the Treatment of Melasma","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2024-04-01","conditions":"Chloasma","enrollment":60},{"nctId":"NCT06183918","phase":"PHASE4","title":"Tranexamic Acid Dosage for Topical Treatment of Anterior Epistaxis","status":"COMPLETED","sponsor":"Izmir Ataturk Training and Research Hospital","startDate":"2021-12-16","conditions":"Anterior Epistaxis, Tranexamic Acid","enrollment":152},{"nctId":"NCT06149091","phase":"EARLY_PHASE1","title":"Control of Iatrogenic Endobronchial Bleeding by Tranexamic Acid, Adrenalin and Hemagglutinase","status":"UNKNOWN","sponsor":"China-Japan Friendship Hospital","startDate":"2023-12-01","conditions":"Iatrogenic Endobronchial Bleeding","enrollment":300},{"nctId":"NCT02918201","phase":"PHASE2","title":"The Effect of Topical Tranexamic Acid on Postoperative Bleeding From Superficial Wounds","status":"COMPLETED","sponsor":"St. Olavs Hospital","startDate":"2020-01-01","conditions":"Postoperative Hemorrhage, Injuries and Wounds","enrollment":36},{"nctId":"NCT05911698","phase":"NA","title":"Fractional co2 Laser Followed by Either Vitamin c or Tranexamic Acid in Treatment of Melasma.","status":"UNKNOWN","sponsor":"Khadija Qenawi","startDate":"2023-10-28","conditions":"Melasma","enrollment":25},{"nctId":"NCT03361345","phase":"PHASE2, PHASE3","title":"Topical 5% Tranexamic Acid as a Treatment for Postinflammatory Hyperpigmentation Due to Acne Vulgaris","status":"WITHDRAWN","sponsor":"Wayne State University","startDate":"2018-11-01","conditions":"Postinflammatory Hyperpigmentation","enrollment":""},{"nctId":"NCT05248321","phase":"NA","title":"Precise Delivery of Tranexamic Acid to Enhance Endoscopic Hemostasis for Peptic Ulcer Bleeding","status":"COMPLETED","sponsor":"National Cheng-Kung University Hospital","startDate":"2022-03-24","conditions":"Peptic Ulcer Hemorrhage","enrollment":60},{"nctId":"NCT05841251","phase":"NA","title":"Phenylephrine Versus Tranexamic Acid to Control Bleeding in Patients Undergoing Inferior Turbinoplasty by Coblation","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2023-05-01","conditions":"Intraoperative Bleeding, Coblation Turbinoplasty","enrollment":80},{"nctId":"NCT01370460","phase":"PHASE2","title":"Topical Tranexamic Acid and Acute Blood Loss in Total Knee Arthroplasty","status":"COMPLETED","sponsor":"Henry Ford Health System","startDate":"2011-06","conditions":"Acute Blood Loss Anemia, Osteoarthritis, Knee","enrollment":101},{"nctId":"NCT01683955","phase":"PHASE1","title":"Topical Tranexamic Acid and Acute Blood Loss in Total Hip Arthroplasty","status":"COMPLETED","sponsor":"Henry Ford Health System","startDate":"2013-01-01","conditions":"Acute Blood Loss Anemia, Osteoarthritis, Hip","enrollment":139},{"nctId":"NCT05708690","phase":"PHASE4","title":"Topical Effect of Tranexamic Acid in Postoperative Bleeding and Blood Products Transfusion After Cardiac Surgery","status":"COMPLETED","sponsor":"Indonesia University","startDate":"2022-10-01","conditions":"Coronary Artery Disease, Valvular Heart Disease, Surgical Blood Loss","enrollment":132},{"nctId":"NCT04696224","phase":"NA","title":"Comparative Use of Tranexamic Acid Intravenous and Topical Application in Intertrochanteric Fractures With PFNA","status":"UNKNOWN","sponsor":"Universidade do Vale do Sapucai","startDate":"2020-12-18","conditions":"Hemorrhage, Fracture Femur","enrollment":90},{"nctId":"NCT05326139","phase":"PHASE4","title":"Topical Tranexamic Acid Application in Rhinoplasty","status":"COMPLETED","sponsor":"Baskent University","startDate":"2021-06-07","conditions":"Ecchymosis; Eyelid, Edema, Rhinoplasty","enrollment":50},{"nctId":"NCT03328832","phase":"PHASE4","title":"Combined Topical Tranexamic Acid With Floseal® in Total Knee Arthroplasty","status":"COMPLETED","sponsor":"Chang Gung Memorial Hospital","startDate":"2017-09-12","conditions":"Osteoarthritis, Knee","enrollment":70},{"nctId":"NCT03570710","phase":"NA","title":"Reducing Blood Loss During Cesarean Hysterectomy for Placenta Accreta Spectrum","status":"COMPLETED","sponsor":"Aswan University Hospital","startDate":"2018-01-01","conditions":"Cesarean Section Complications","enrollment":80},{"nctId":"NCT02664909","phase":"PHASE4","title":"Topical (Intra-Articular) Tranexamic Acid and Transfusion Rates Following Hip Hemiarthroplasty","status":"COMPLETED","sponsor":"UConn Health","startDate":"2016-01-01","conditions":"Femoral Neck Fractures","enrollment":36},{"nctId":"NCT02650856","phase":"PHASE3","title":"Blood Loss Reduction After Total Knee Arthroplasty. Comparison Topical Tranexamic Acid vs Platelet Rich Plasma","status":"COMPLETED","sponsor":"Universidad Autonoma de Nuevo Leon","startDate":"2015-09","conditions":"Osteoarthritis","enrollment":40},{"nctId":"NCT03738527","phase":"PHASE4","title":"SEroma Reduction pOst MAstectomy \"SEROMA Study\"","status":"UNKNOWN","sponsor":"Hamilton Health Sciences Corporation","startDate":"2019-10-07","conditions":"Seroma Complicating A Procedure, Hematoma Postoperative, Breast Cancer","enrollment":100},{"nctId":"NCT01622946","phase":"PHASE4","title":"The Effect of Topical Application of Tranexamic Acid in Total Hip Arthroplasty Through the Direct Anterior Approach","status":"COMPLETED","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2012-04","conditions":"Total Hip Arthroplasty, Postoperative Blood Loss","enrollment":80},{"nctId":"NCT04599205","phase":"PHASE2, PHASE3","title":"Evaluation of Laser and Tranexamic Acid in Treatment of Melasma","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2020-12","conditions":"Melasma","enrollment":40},{"nctId":"NCT03706339","phase":"NA","title":"Reducing Blood Loss During Cesarean Section by Topical Versus IV Tranexamic Acid","status":"COMPLETED","sponsor":"Aswan University Hospital","startDate":"2018-11-01","conditions":"Cesarean Section Complications","enrollment":450},{"nctId":"NCT02278263","phase":"PHASE4","title":"Tranexamic Acid in Knee Joint Surgery","status":"COMPLETED","sponsor":"Andrew G Hill, MBChB, MD (Thesis), EdD, FACS, FRACS","startDate":"2014-12","conditions":"Osteoarthritis","enrollment":150},{"nctId":"NCT01937559","phase":"PHASE4","title":"Topical Tranexamic Acid (TXA) in Joint Arthroplasty","status":"COMPLETED","sponsor":"The Hawkins Foundation","startDate":"2013-04","conditions":"Osteoarthritis, Hip Arthropathy, Shoulder Arthropathy","enrollment":188},{"nctId":"NCT03386656","phase":"PHASE3","title":"Efficacy and Safety of Topical Application of Tranexamic Acid for Saving Blood Losses in Patients Subjected to Prosthetic Knee Surgery","status":"COMPLETED","sponsor":"Fundación Pública Andaluza Progreso y Salud","startDate":"2017-11-28","conditions":"Osteoarthritis, Knee","enrollment":150},{"nctId":"NCT03623789","phase":"PHASE4","title":"Blood-saving Effect of Combined Intravenous Tranexamic Acid With Topical Floseal® Application Total Hip Arthroplasty","status":"UNKNOWN","sponsor":"Chang Gung Memorial Hospital","startDate":"2018-08-15","conditions":"Hip Replacement, Total","enrollment":90},{"nctId":"NCT03923062","phase":"PHASE4","title":"Different Dermatological Approaches the Treatment of Melasma","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2020-02-01","conditions":"Melasma","enrollment":40},{"nctId":"NCT01940523","phase":"PHASE4","title":"Randomized Controlled Trial of Tranexamic Acid in Total Knee Arthroplasty: Intravenous vs. Topical","status":"COMPLETED","sponsor":"Hospital for Special Surgery, New York","startDate":"2013-05","conditions":"Osteoarthritis","enrollment":640},{"nctId":"NCT03741075","phase":"NA","title":"Topical Tranexamic Acid Plus Bilateral Uterine Artery Ligation During Cesarean Delivery","status":"UNKNOWN","sponsor":"Aswan University Hospital","startDate":"2018-12-01","conditions":"Cesarean Section Complications","enrollment":100},{"nctId":"NCT01727843","phase":"PHASE3","title":"Topical Application of Tranexamic Acid and Postoperative Blood Loss in Femoral Neck Fractures","status":"TERMINATED","sponsor":"Dr. Jeff Yach","startDate":"2013-04","conditions":"Femoral Neck Fracture","enrollment":15},{"nctId":"NCT03585179","phase":"PHASE3","title":"Oral and Topical Tranexamic Acid for the Treatment of Melasma","status":"UNKNOWN","sponsor":"Centro Dermatológico Dr. Ladislao de la Pascua","startDate":"2018-08-01","conditions":"Melasma, Chloasma, Melanosis","enrollment":120},{"nctId":"NCT02393300","phase":"PHASE3","title":"Comparison of Topical Versus Intravenous Tranexamic Acid in TKA","status":"COMPLETED","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2014-07","conditions":"Total Blood Loss","enrollment":174},{"nctId":"NCT01866943","phase":"PHASE2","title":"Role of Topical Tranexamic Acid in Total Hip Arthroplasty","status":"TERMINATED","sponsor":"Northwell Health","startDate":"2011-11","conditions":"Post Operative Blood Loss","enrollment":41},{"nctId":"NCT02106962","phase":"PHASE4","title":"Use of Topical Tranexamic Acid and Bacitracin in Dialysis Patients","status":"COMPLETED","sponsor":"California Institute of Renal Research","startDate":"2014-04","conditions":"Arteriovenous Fistula","enrollment":17},{"nctId":"NCT03122782","phase":"PHASE3","title":"Hemostatic Effect of Intrauterine Instillation Of Tranexamic Acid In Hysteroscopic Myomectomy","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2017-08-01","conditions":"Surgical Blood Loss, Fibroid","enrollment":80},{"nctId":"NCT02063035","phase":"PHASE4","title":"Effectiveness Study of the Drug Tranexamic Acid to Reduce Post-surgery Blood Loss in Spinal Surgery","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2012-08","conditions":"Lumbar Spinal Stenosis, Thoracic Spinal Stenosis","enrollment":29},{"nctId":"NCT02865174","phase":"PHASE4","title":"Topical Tranexamic Acid and Floseal® in Total Knee Arthroplasty","status":"UNKNOWN","sponsor":"Chang Gung Memorial Hospital","startDate":"2016-09","conditions":"Osteoarthritis, Knee","enrollment":90},{"nctId":"NCT02492087","phase":"PHASE3","title":"Topical Tranexamic Acid in Caesarean Section","status":"UNKNOWN","sponsor":"Dr Meng-Li Lee","startDate":"2015-08","conditions":"Postpartum Haemorrhage","enrollment":84},{"nctId":"NCT02312440","phase":"PHASE3","title":"Comparison of Topical and Intravenous Tranexamic Acid in Total Hip Arthroplasty","status":"COMPLETED","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2014-10","conditions":"Blood Loss","enrollment":173},{"nctId":"NCT02453802","phase":"PHASE4","title":"Comparison of Topical and Infusion Tranexamic Acid After Total Knee Arthroplasty","status":"UNKNOWN","sponsor":"Chang Gung Memorial Hospital","startDate":"2015-06","conditions":"Osteoarthritis, Knee","enrollment":90},{"nctId":"NCT01519245","phase":"PHASE3","title":"Topical Application of Tranexamic Acid to Reduce Post-operative Bleeding in Coronary Artery Bypass Surgery","status":"COMPLETED","sponsor":"University of Saskatchewan","startDate":"2011-12","conditions":"Coronary Artery Disease","enrollment":44},{"nctId":"NCT01594671","phase":"PHASE3","title":"Tranexamic Acid for Unilateral Total Knee Arthroplasty","status":"COMPLETED","sponsor":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","startDate":"2012-02","conditions":"Blood Loss","enrollment":150},{"nctId":"NCT01600599","phase":"NA","title":"Reducing Post Operative Bleeding Following Cabg","status":"COMPLETED","sponsor":"University of Malaya","startDate":"2011-01","conditions":"Post CABG Bleeding","enrollment":40},{"nctId":"NCT01260818","phase":"NA","title":"Topical Application of Tranexamic Acid Reduces Postoperative Blood Loss in Total Hip Arthroplasty","status":"UNKNOWN","sponsor":"The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine","startDate":"2010-12","conditions":"Hip Replacement, Postoperative Hemorrhage","enrollment":100},{"nctId":"NCT00985920","phase":"PHASE4","title":"Topical Tranexamic Acid for Total Knee Arthroplasty","status":"COMPLETED","sponsor":"University Health Network, Toronto","startDate":"2007-09","conditions":"Surgical Blood Loss, Total Knee Arthroplasty","enrollment":125}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["KAPRON (AMOUN Pharmaceutical co.)"],"phase":"phase_3","status":"active","brandName":"Topical application Tranexamic acid","genericName":"Topical application Tranexamic acid","companyName":"Ain Shams University","companyId":"ain-shams-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Tranexamic acid works by inhibiting the activation of plasminogen to plasmin, thereby reducing fibrinolysis and improving hemostasis. Used for Surgical bleeding prevention, Menstrual bleeding disorders.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}